Increased selenium levels associated with reduced risk of colorectal cancer
the ONA take:
Increased levels of selenium, a mineral found in soil and some foods that is key to metabolism function, have been associated with a lower risk of colorectal cancer.
Research conducted by investigators based at Newcastle University, UK, the International Agency for research on Cancer (IARC-WHO), and the Royal College of Surgeons in Ireland, determined that Europeans average 80 micrograms of selenium, well below the 110-170 range seen in North America.
These lower selenium averages are probably due to a lower selenium soil content in Europe. (Current recommended dietary allowance [RDA] of selenium for adults is at least 55 micrograms per day, with a safe upper limit of 400 micrograms per day.)
The team examined selenium levels in the blood as well as selenoprotein O P levels, and they determined that a higher selenium level correlates to a lower colorectal cancer risk, with a greater correlation for women.
Although they acknowledge the need for additional study, they feel that a dietary supplement containing selenium could be beneficial for populations in which naturally occurring selenium levels are insufficient.
Increased levels of selenium have been associated with a lower risk of colorectal cancer.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Baseline PSA Levels in Midlife Could Predict Risk of Lethal Prostate Cancer
- Community Breast Navigation Program Improved Breast Screening Rates in Underserved African American and Latino Women
- Live-streamed Videos Address End-of-Life Planning, Decision-making
- Metastatic Disease Linked to Patients Reporting Diminished QoL
- History of Bilateral Salpingo-oophorectomy, Hormone Replacement Therapy Are Predictive of Breast Density at Cancer Diagnosis
- Mammographically Occult Contralateral Breast Cancer Detection is Effective With Preoperative MRI
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|